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ART ICLE Open Ac ce s s
NF-κB2 signalling in enteroids modulates
enterocyte responses to secreted factors from
bone marrow-derived dendritic cells
Lauren G. Jones1, Andra Vaida1, Louise M. Thompson1, Felix I. Ikuomola1, Jorge H. Caamaño 2, Michael D. Burkitt1,
Fabio Miyajima3,4, Jonathan M. Williams5, Barry J. Campbell 1, D. Mark Pritchard1 and Carrie A. Duckworth 1
Abstract
Alternative pathway NF-κB signalling regulates susceptibility towards developing inﬂammatory bowel disease (IBD),
colitis-associated cancer and sepsis-associated intestinal epithelial cell apoptosis and shedding. However, the cell
populations responsible for the perturbed alternative pathway NF-κB signalling in intestinal mucosal pathology remain
unclear. In order to investigate the contribution of the epithelial compartment, we have tested whether NF-κB2
regulated transcription in intestinal epithelial cells controls the intestinal epithelial response to cytokines that are
known to disrupt intestinal barrier permeability. Enteroids were generated from the proximal, middle and distal
regions of small intestine (SI) from C57BL/6J wild-type mice and displayed region-speciﬁc morphology that was
maintained during sub-culture. Enteroids treated with 100 ng/mL TNF were compared with corresponding regions of
SI from C57BL/6J mice treated systemically with 0.33 mg/kg TNF for 1.5 h. TNF-induced apoptosis in all regions of the
intestine in vitro and in vivo but resulted in Paneth cell degranulation only in proximal tissue-derived SI and enteroids.
TNF also resulted in increased enteroid sphericity (quantiﬁed as circularity from two-dimensional bright ﬁeld images).
This response was dose and time-dependent and correlated with active caspase-3 immunopositivity. Proximal tissue-
derived enteroids generated from Nfκb2−/− mice showed a signiﬁcantly blunted circularity response following the
addition of TNF, IFNγ, lipopolysaccharide (LPS) activated C57BL/6J-derived bone marrow-derived dendritic cells
(BMDC) and secreted factors from LPS-activated BMDCs. However, Nfκb1−/− mouse-derived enteroids showed no
signiﬁcant changes in response to these stimuli. In conclusion, the selection of SI region is important when designing
enteroid studies as region-speciﬁc identity and response to stimuli such as TNF are maintained in culture. Intestinal
epithelial cells are at least partially responsible for regulating their own fate by modulating NF-κB2 signalling in
response to stimuli known to be involved in multiple intestinal and systemic diseases. Future studies are warranted to
investigate the therapeutic potential of intestinal epithelial NF-κB2 inhibition.
Introduction
The intestine is lined by a single layer of columnar
epithelial cells that function to maintain a barrier between
luminal contents and the body1,2. Barrier function is
maintained by the tight regulation of intestinal epithelial
cell proliferation, apoptosis and cell shedding rates which
are themselves modulated by several factors, including
age, genetic background, dietary components, intestinal
microbiota, enterally and parenterally administered drugs
and other environmental factors3. Dysregulation of these
cellular processes results in the break-down of the
intestinal barrier and this is thought to be a contributing
factor to the development of multiple diseases. We have
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recently shown that defective intestinal barrier function
caused by cell shedding in the terminal ileum predicts
relapse of inﬂammatory bowel disease (IBD) in humans4.
Defects in intestinal barrier function may also be involved
in the pathogenesis of systemic conditions, such as
metabolic endotoxaemia and sepsis5,6.
Several pro-inﬂammatory cytokines are present at
increased concentrations in the circulation, intestinal
lumen and lamina propria of the intestine during active
IBD, infectious diarrhoea, coeliac disease and sepsis7–12.
Tumour necrosis factor (TNF) is a well characterised
cytokine that is produced in these conditions and is a key
mediator of mucosal pathology3,13. Elevated TNF con-
centrations in excess of 63 ng/g stool have been docu-
mented in humans in response to Shigella ﬂexneri
infection11. Anti-TNF therapies are also widely used
clinically to ameliorate active Crohn’s disease14.
We have recently shown that the administration of
lipopolysaccharide (LPS) or its downstream effector, TNF,
by intraperitoneal injection to mice results in a massive
induction of epithelial apoptosis and cell shedding from
the SI villus tip within 1.5 h4,15–17. This rapid onset of
active caspase-3 positively stained shedding cells subse-
quently resulted in villus atrophy and was accompanied by
ﬂuid effusion into the SI lumen and diarrhoea, but was
largely diminished at 3 h post LPS injection17. However,
increased efﬂux of FITC-dextran (FD4) from the intestinal
lumen into the circulation following LPS treatment was
observed at later time-points17, suggesting that defects in
intestinal barrier function persist once cell shedding and
apoptosis have subsided, until complete restitution of the
epithelium has been achieved. The regenerative capacity
of the intestinal epithelium is remarkable. Cell turnover in
the epithelium is normally around 5 days with around
1400 cells shed from a single mouse villus tip per day18.
We would therefore anticipate that barrier function could
take up to 5 days to be restored following extensive epi-
thelial cell loss by apoptosis and cell shedding once
inﬂammatory stimuli such as TNF and interferon γ (IFNγ)
have been removed. Understanding the mechanisms
underpinning intestinal epithelial cell protection from
cytokine-mediated injury will enable the future develop-
ment of therapeutics for several intestinal and systemic
diseases.
The NF-κB family of transcription factors consists of 5
members (NF-κB2 (p52), RelB, NF-κB1 (p50), c-Rel, and
RelA (p65)) and regulate multiple cellular processes19. We
have recently identiﬁed components of the alternative NF-
κB signalling pathway that are important in modulating
the susceptibility to IBD, colitis-associated cancer and
intestinal epithelial apoptosis and cell shedding in mice.
Nfκb2−/− mice were resistant to dextran sulphate sodium
(DSS)-induced colitis and azoxymethane/DSS-induced
colonic adenoma formation20 and were also resistant to
the induction of LPS and TNF-induced SI apoptosis and
cell shedding in vivo16,17. Infection studies have also
shown that Nfκb2−/− mice have a reduced ability to clear
the gut helminth Trichuris muris21 and the gastric
pathogen Helicobacter felis, the latter observation being
associated with reduced gastric preneoplastic pathology
owing to a defective immune response22. The complex
in vivo nature of these studies to date, has made it
impossible to determine the importance of each cellular
compartment (e.g., immune or epithelial) in regulating the
intestinal response to damage-inducing stimuli. The
majority of studies characterising alternative pathway NF-
κB signalling are also focused on immune cell mechan-
isms which may be differentially regulated in other cel-
lular compartments. Therefore, we have now generated a
SI enteroid model to assess the interactions between the
intestinal epithelium and speciﬁc immune cell derived
cytokines that are known to be elevated in intestinal and
systemic disease, and to determine the importance of
epithelial cell-speciﬁc alternative pathway NF-κB signal-
ling in regulating the epithelial cell response to cytokine-
induced pathology.
Dendritic cells are present throughout the lamina
propria of the gut and contribute to innate and adaptive
immunity thus regulating gut homoeostasis. Direct
bidirectional interaction of dendritic cells with the epi-
thelium is believed to maintain the dendritic cell
population in a tolerogenic state and this protects the
intestinal epithelium from inappropriate immune cell-
derived attack23. Whilst dendritic cells are the most
potent antigen presenting cell population, they are also
activated by pro-inﬂammatory cytokines or oxidative
stress and are conditioned by their surrounding micro-
environment24. Cytokines and chemokines released by
dendritic cells along with other lamina propria immune
cell populations can modulate intestinal barrier integ-
rity, intestinal cell proliferation and cell death25. Our
previous whole mouse global Nfκb2 knockout stu-
dies17,20,22 have limited our ability to dissect the
importance of alternative pathway NF-κB signalling
within epithelial and immune compartments in reg-
ulating the susceptibility of the intestinal epithelium to
cytokine-induced injury. We therefore generated a bone
marrow-derived dendritic cell (BMDC) reconstituted
intestinal organoid model to assess the role of NF-κB2
in regulating intestinal epithelial cell-speciﬁc responses
to secreted factors from BMDCs.
We hypothesise that Nfκb2 activation within intestinal
epithelial cells sensitises them to the induction of apop-
tosis by pro-inﬂammatory cytokines that are upregulated
in intestinal tissues and systemically during active intest-
inal disease and bacteraemia. We have therefore explored
whether Nfκb2 inhibition within intestinal epithelia could
be a potential therapeutic approach to ameliorating
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inﬂammation-associated intestinal disease using a novel
reconstituted intestinal organoid co-culture model.
Results
Regional differences are observed in enteroid morphology
The small intestine (SI) displays regional differences in
structure and function. The expression of several genes is
altered along the cephalocaudal axis in vivo and this
region-speciﬁc identity has previously been shown to be
maintained in enteroid culture26,27. We therefore gener-
ated organoids from proximal, middle and distal 2 cm
segments of murine SI from female C57BL/6J mice and
assessed their morphological changes over 10 consecutive
passages. Enteroids derived from the three distinct areas
displayed morphological differences between regions and
these did not alter following repeated passage. At days
3–5 post passage, proximal SI derived enteroids had the
longest (116 ± 3 μm) and most abundant crypt domains
(7.22 ± 0.26/enteroid) with smooth surfaces and a polar-
ised Paneth cell distribution at the base of crypts, whilst
the distal SI derived enteroids had a smaller number of
crypt domains (4.04 ± 1.02/enteroid) which were shorter
(89 ± 4 μm) and displayed a more rounded and rugged
appearance with a less polarised Paneth cell distribution
with these differentiated cells also being found further
along the crypt axes (Fig. 1a). Middle SI derived enteroids
had 5.22 ± 1.90 crypts per enteroid that were 91 ± 11 μm
in length and showed the greatest degree of variation in
crypt length and number and Paneth cell distribution,
suggestive of an intermediate phenotype.
TNF induces enteroid apoptosis and Paneth cell depletion,
but does not modulate enteroid proliferation
We previously identiﬁed subtle regional differences in
the murine SI in vivo in response to intraperitoneally
administered LPS. A greater extent of villus blunting was
observed in the proximal SI compared with other SI
regions17. We therefore investigated the apoptotic and
proliferative responses to a downstream effector of LPS,
TNF, in region-speciﬁc enteroid cultures compared to
histological sections taken from the same regions of the
intestine in vivo. Baseline amounts of apoptosis in both
untreated SI and in enteroid culture regardless of region
were low, however, a small increase in the percentage of
active caspase-3 positive cells was observed along the
cephalocaudal axis in both systems (Fig. 1b–e). As
expected, intraperitoneal injection of 0.33 mg/kg TNF-
induced a signiﬁcant increase in apoptotic cells at the
villus tip after 1.5 h (Fig. 1b, d), whilst 100 ng/ml TNF-
induced apoptosis to a similar extent in enteroids after
24 h (Fig. 1c, e).
Paneth cells are important for maintaining the intestinal
stem cell niche, although the exact mechanisms by which
this cell population supports the proliferative capacity and
number of neighbouring crypt base columnar cells remain
unknown. However, TNF has previously been shown to
induce Paneth cell dysfunction in vivo28, and this could
potentially impact on the regenerative capacity of the
intestinal epithelium. We therefore investigated whether
TNF modulated Paneth cell number in SI tissue and in
enteroids as this could impact on crypt-villus growth
dynamics. TNF administration caused a more marked and
signiﬁcant reduction in Paneth cell number in the prox-
imal SI and proximal tissue-derived enteroids compared
with other SI regions (Fig. 2a, b) suggesting that TNF may
modulate the intestinal stem cell niche in different ways
within the proximal SI compared with other intestinal
regions. Olfactomedin-4 (Olfm4) is a putative active stem
cell marker that also labels early transit-amplifying cells.
Olfm4 expression was not altered in SI tissues treated
with TNF but due to the distribution differences in cel-
lular location of Olfm4 observed in enteroids, Olfm4
expressing cells were not possible to quantify reliably
(Supplementary Fig. 1). We also wanted to test whether
another abundant secretory cell type was affected by the
addition of TNF and found that the goblet cell population
in different regions of SI and in enteroids was not
modulated by the addition of TNF (Supplementary Fig. 2).
Proliferation in the SI in vivo occurs within the transit-
amplifying region of the crypt; a distinctly different part of
the crypt-villus axis to the villus tip, which is the region
most susceptible to apoptosis in response to systemically
administered TNF. As we have shown that TNF causes
apoptosis and Paneth cell depletion at the dose and time-
points tested in mice in vivo and in enteroids, we wanted
to determine whether this treatment had any impact on
intestinal proliferation. Proliferation indicated by Ki67
positively stained nuclei was identiﬁed in the crypt
domains of whole SI tissue and enteroids. TNF treatment
had no signiﬁcant effect on cellular proliferation either
in vivo or in enteroid culture, in any of the three SI
regions at the doses and time points that showed an
increased apoptotic response and Paneth cell depletion
(Fig. 2c, d).
Apoptosis and resultant cell shedding into the lumen
correlate positively with enteroid circularity
Villus shortening occurs in vivo as a result of an
increased rate of apoptosis and cell shedding from the
villus tip with no compensatory increase in cellular pro-
liferation (Figs. 1 and 2)17. Similar atrophy also occurs in
enteroid cultures. As a result of cell loss by apoptosis with
no accompanying change in cellular proliferation (Figs. 1
and 2), cells are shed into the enteroid lumen and these
are not immediately replaced. Junctional complexes hold
remaining epithelial cells together whilst there is likely
pressure from the build-up of apoptotic bodies within
enteroid lumens. This results in the enteroids gaining a
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more spherical morphology. We have quantiﬁed this
enteroid ‘rounding’ in terms of circularity from 2-
dimensional images and have validated this as a repro-
ducible and robust method of cell death analysis in
enteroids following cytokine treatment (materials and
methods). Three days post passage, untreated enteroids
had circularity values of ~0.35, however, circularity
increased to ~0.65 48 h following 100 ng/mL TNF and
~0.9 with conditioned media from LPS-activated BMDCs
in C57BL/6J proximal tissue-derived enteroids (Fig. 3a).
We validated the reproducibility of the scoring method by
assessment of intra-scorer variability where the same
person (L.J.) scored images from the same 12 enteroids
with a range of different circularities 1 week apart (Fig.
3b), and inter-scorer variability where two different blin-
ded scorers (L.J. and C.D.) assessed enteroid circularity
from the same 12 enteroid images (Fig. 3c). We also
determined that there was no correlation between
Fig. 1 Enteroids show regional differences in morphology and respond to TNF similarly to native SI tissue. Bright ﬁeld micrographs of
enteroids derived from proximal, middle and distal sections of C57BL/6J SI (a). Proximal, middle and distal sections of SI tissue taken from untreated
and TNF (0.33 mg/kg, 1.5 h) treated C57BL/6J mice (b) and enteroids generated from proximal, middle and distal regions of SI untreated or treated
with TNF (100 ng/mL 24 h) (c) immunohistochemically stained for active caspase-3. Quantiﬁcation of active caspase-3 positive epithelial cells from
untreated (white) and TNF treated (black) SI epithelia (d) and enteroid culture (e). For animal study, quantiﬁed from n= 6 mice per group; for
enteroid study n= 6, N= 3, *p < 0.05, **p < 0.01. Scale bars= 100 µm.
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enteroid area and circularity as long as organoids were
above a critical size at the start of each experiment, which
equated to 3 days post passage or an initial baseline cir-
cularity value <0.4 (Fig. 3d).
To further validate the assessment of circularity as a
reliable indicator of cytokine-induced cell death in
proximal tissue-derived enteroids, we observed a good
positive correlation (R2= 0.6) between enteroid circular-
ity and active caspase-3 immunohistochemical staining
(Fig. 3e). TNF activates apoptosis via caspase-8 and active
caspase-8 is observed at the villus tip during intestinal cell
shedding29. Active caspase-8 was not detected at later
Fig. 2 TNF causes Paneth cell degranulation in proximal SI but does not change the rate of cell proliferation. Proximal SI and enteroids
stained with Sirius red (a). Percentage of Sirius red stained Paneth cells in untreated (white) and TNF treated (black) proximal, middle and distal
derived SI (top) and enteroids (bottom) (b). Proximal SI and enteroids stained with Ki67 (c). Percentage of Ki67 stained epithelial cells in untreated
(white) and TNF treated (black) proximal, middle and distal derived SI (top) and enteroids (bottom) (d). For animal study quantiﬁed from n= 6 mice
per group, for enteroid study n= 6, N= 3, *p < 0.05. Scale bars= 100 µm.
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time-points during enteroid studies (Supplementary Fig.
3). As enteroids derived from the middle or distal seg-
ments of the SI displayed a more rounded appearance in
culture at baseline (Fig. 1a), they also showed a blunted
response to TNF in terms of increased circularity com-
pared with proximal tissue-derived enteroids (Fig. 3f).
Future studies should therefore consider the use of the
circularity method for determining enteroid response to
injury, however this method is not suitable for comparing
responses between enteroid regions. We therefore used
proximal tissue-derived enteroids for the remainder of
this study.
Alternative NF-κB pathway signalling in small intestinal
epithelial cells regulates the response to cytokine-induced
injury
We have previously shown that Nfκb2−/− mice are
resistant to TNF-induced villus tip apoptosis and cell
shedding compared with their wild-type C57BL/6J coun-
terparts17. However, the mechanism responsible for this
resistance could not be determined during these in vivo
studies as it was impossible to quantify the contribution of
speciﬁc cellular compartments such as epithelial cells or
immune cells. Using proximal tissue-derived enteroids,
we have now assessed the importance of NF-
κB2 signalling speciﬁcally in the epithelial cell compart-
ment in response to TNF and IFNγ stimulation. Both
TNF and IFNγ caused C57BL/6J and Nfκb1−/− mouse-
derived enteroids to undergo morphological changes and
round up over a 24-h period, with further noticeable
rounding after 48 h (Fig. 4a, b). This response was how-
ever blunted in Nfκb2−/− enteroids (Fig. 4c). A dose-
dependent increase in circularity was observed in C57BL/
6J and Nfκb1−/− enteroids from 1 to 1000 ng/mL TNF
and from 0.1 to 100 ng/mL IFNγ at both 24- and 48-h
post treatment, however, no such increase was observed
in Nfκb2−/− enteroids (Fig. 5a–f) suggesting that alter-
native pathway NF-κB activation is an important mod-
ulator of the intestinal epithelial cell response to injury.
LPS-activated bone marrow-derived dendritic cells induce
enteroid rounding in a co-culture model and this is
inhibited by epithelial NF-κB2 deletion
LPS administration to mice in vivo resulted in abun-
dant villus tip apoptosis and cell shedding 1.5 h fol-
lowing intraperitoneal injection. We have previously
shown Tnfr1−/− and Tlr4−/− mice to be resistant to
LPS-induced cell shedding, suggesting that LPS acts via
Fig. 3 Validation of circularity assessment as a marker of TNF-induced apoptosis in enteroid culture. Light micrograph examples of proximal
tissue-derived enteroids either untreated 3 days post passage (left), 48 h following 100 ng/ml TNF (middle) and 48 h following treatment with CM
from LPS-activated BMDCs (right) traced in yellow using Image J (a). Quantiﬁcation of circularity from 12 different enteroids administered with a
range of treatments over different experiments and re-scored by the same observer (b) and by an independent second observer (c). Correlation
between relative enteroid area and circularity for 130 individual enteroids at baseline (d), small organoids at baseline have high circularity values and
need to be excluded from further analysis (grey box). Percentage active-caspase 3 positive cells were correlated with enteroid circularity from
organoids selected at 0, 24 and 48 h post treatment with 100 ng/ml TNF (e). Change in circularity between three enteroid regions at baseline (white
bars) and 24 h after 100 ng/ml TNF (black bars). Scale bars= 100 µm.
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Fig. 4 TNF induces circularity of C57BL/6 but not Nfκb2−/− enteroids. TNF (100 ng/mL) induces enteroid rounding of C57BL/6J (a) and Nfκb1−/−
(b) proximal tissue-derived enteroids but not Nfκb2−/− proximal tissue-derived enteroids (c) at 24 and 48 h time points following treatment. Scale
bars= 100 µm.
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TLR4 on immune cells to induce ligands that bind the
TNFR1 on epithelial cells to initiate the shedding pro-
cess17. Dendritic cells have important functions in the
innate and adaptive immune systems and are activated
by LPS. We therefore co-cultured C57BL/6J-derived
BMDCs with C57BL/6J, Nfκb1−/− or Nfκb2−/− enter-
oids and tested BMDCs that had or had not been acti-
vated by LPS. The direct application of 1 μg/mL LPS or
unstimulated BMDCs had no morphological effect on
any enteroid genotype (Fig. 6a) and we did not observe
any signiﬁcant differences in enteroid circularity fol-
lowing treatment (Fig. 6b–d). Interestingly, co-culture
of C57BL/6J and Nfκb1−/− enteroids with LPS-activated
BMDCs resulted in enteroid rounding (Fig. 6a) and a
signiﬁcant increase in enteroid circularity at both 24-
and 48-h post treatment (Fig. 6b, c). However, Nfκb2−/−
enteroids were resistant to rounding and showed no
signiﬁcant increase in circularity in co-culture with LPS-
activated BMDCs at 24 or 48 h (Fig. 6a, d). This suggests
that NF-κB2 signalling speciﬁcally in intestinal epithelial
cells is modulated by the interaction with dendritic cells.
Secreted factors from LPS-activated bone marrow-derived
dendritic cells are responsible for organoid injury
We sought to determine whether the direct action of
BMDC secreted factors on epithelial cells were respon-
sible for the observed increase in C57BL/6J-derived
enteroid circularity following stimulation with LPS.
Conditioned media from unstimulated and LPS-
stimulated BMDCs was placed onto C57BL/6J enteroids.
Conditioned media from BMDCs did not induce an
increase in enteroid circularity, however, conditioned
media from LPS-activated BMDCs induced a signiﬁcant
increase in enteroid circularity at both 24- and 48-h post
treatment (Fig. 7a, b). We assessed the cytokines that had
been secreted by BMDCs into this conditioned media
following stimulation with LPS and determined that sev-
eral pro-inﬂammatory cytokines were upregulated. Initial
analysis suggested that the amounts of IL-2, IL-4, IL-5 and
IL-23 produced were minimal or below the lower limit of
detection, hence these cytokines were not considered in
subsequent experiments. TNF was upregulated in
response to LPS and reached maximal concentrations of
Fig. 5 TNF and IFNγ-induced circularity is blunted in Nfκb2−/− enteroids. Enteroid circularity is dose-dependently increased at 24 and 48 h time-
points by treatment with TNF (a–c) and IFNγ (d–f) in C57BL/6J-derived enteroids (a, d) and Nfκb1−/− enteroids (b, e), but is blunted in Nfκb2−/−
enteroids (c, f). N= 4, n= 6, *p < 0.05, **p < 0.01, **p < 0.001 compared with untreated of the same genotype at the same time point.
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around 1 ng/mL (Table 1). However, this concentration
was not high enough to stimulate an increase in enteroid
circularity alone (Figs. 4 and 5). Signiﬁcant increases in
IL-6, IL-1β, IL-17A and IL-15 were also detected in the
media of LPS-activated BMDCs in co-culture with
enteroids and these cytokines may therefore have
Fig. 6 Nfκb2−/− enteroids showed a blunted response to co-culture with LPS activated BMDCs. Enteroids were generated from the proximal SI
of C57BL/6J, Nfκb1−/− and Nfκb2−/−mice and were either left untreated, treated with 1 µg/ml LPS, 5 × 104 C57BL/6J-derived BMDC or 5 × 104 C57BL/
6J-derived BMDC plus 1 µg/ml LPS and subjected to light microscopy at 48 h (a). Circularity assessment was conducted at 0, 24 and 48 h time points
for each stimulus in C57BL/6J (b), Nfκb1−/− (c) and Nfκb2−/− (d) enteroids. N= 3, n= 6, *p < 0.05, **p < 0.01 compared with untreated of the same
enteroid genotype at the same time point. Scale bars= 100 µm.
Fig. 7 Conditioned media from LPS-activated BMDCs induced enteroid rounding. Enteroids derived from the proximal SI of C57BL/6J mice
were untreated or treated with 50% conditioned media (CM) generated from 1 × 105 BMDC/ml that were previously either untreated or treated with
1 µg/ml LPS for 48 h (a). Circularity assessment of enteroids was conducted at 0, 24 and 48 h time points for each stimulus (b). N= 3, n= 6, **p < 0.01
compared with untreated at the same time point. Scale bars= 100 µm.
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contributed to the observed increase in enteroid circu-
larity. Secreted factors from dendritic cells are therefore
able to modulate intestinal epithelial cell response to
injury, which can be modelled in an enteroid system.
Discussion
Recent advances have enabled long-term three-dimen-
sional culture of the mammalian SI epithelium30–32.
However, many published studies have not considered the
differences that exist in structure and function between
different anatomical regions of the SI in vivo. The duo-
denum, jejunum and ileum are each specialised com-
partments which have distinct absorptive and secretory
functions26,33–36. Previous studies in human and mouse
enteroids have indicated that cultures retain their region-
speciﬁc identities following multiple passage, in the
absence of mesenchymal cell signalling or other niche
factors27. For instance, the Gata 4 transcription factor is
highly expressed in all epithelial cells of the duodenum,
but shows greatly reduced expression further down the
cephalocaudal axis, with no expression being detected in
the terminal ileum26,27. Gata 4 has been shown to activate
jejunal-speciﬁc genes such as Clnd2 (encoding Claudin-2
protein) but represses ileal-speciﬁc genes such as Slc10a2
(solute carrier family 10, member 2) and Fabp6 (encoding
fatty acid binding protein 6)26,37. Overexpression of
Claudin-2 has been associated with inﬂammatory bowel
disease and coeliac disease38 and is also upregulated in the
intestine within 1 h of experimentally induced sepsis39.
Regional differences in susceptibility occur for each of
these pathologies and this is likely to result from differ-
ences in gene expression and environmental cues.
We therefore considered SI location when establishing
enteroids and have identiﬁed variations in growth
dynamics between three different regions of the intestine
at baseline and following TNF treatment. These differ-
ences were also observed in parallel in vivo studies. In
particular, Paneth cell numbers were increased from
proximal to distal SI in vivo and in enteroid culture and
we noted a greater amount of Paneth cell degranulation in
the proximal SI both in vitro and in vivo in response to
TNF. Previous studies have indicated that there is a
greater degree of LPS-induced SI shedding and villus
atrophy in the proximal SI compared with other regions17,
however, loss of Paneth cell function within the crypt
domains may also contribute to an alteration in the SI
stem cell niche, thus perturbing cell production and
dynamics further along the crypt-villus axis. We did not
observe differences in the proliferative compartment
along the length of the intestine by Ki67 immunohis-
tochemistry (IHC), however, a large population of cells
are labelled by Ki67 in both systems and more subtle
differences in the proliferative compartment may be
apparent by using more sensitive detection methods. It
was difﬁcult to compare the overall growth rate of orga-
noids between the three regions, however, distal tissue-
derived enteroids were more difﬁcult to establish than
those from other regions of the SI and displayed mor-
phological differences that were maintained for greater
than ten passages. Therefore, future studies should con-
sider that following successive culture, proximal tissue-
derived enteroids may outcompete distal tissue-derived
derived enteroids in a mixed population.
One of the major cytokines that is responsible for the
development of IBD and which is a major contributor to
the cytokine storm and multiple organ dysfunction
(including the gut epithelium) that occurs in sepsis is
TNF4,7,17. The direct impact of TNF on enteroid mor-
phology was striking. Over a period of 48 h, enteroids
adopted a rounded appearance and many became almost
spherical. This altered morphology was a likely result of
increased apoptosis and cell shedding into the enteroid
lumen. Analogous to bubble formation, a spherical
appearance may result from the line of least tension
across tight and adherens junctions with pressure build up
from shed cellular debris and secretions within the
enteroid lumen. The observed change in enteroid mor-
phology was assessed by measuring circularity and this
correlated linearly with active caspase-3 expression, thus
validating the technique as a method for analysing cell
death in this setting. This technique is much quicker than
other similarly reported methods such as the assessment
of branching morphogenesis by assessing the number and
length of crypt buds40. The circularity assessment method
Table 1 Cytokines produced by C57BL/6J proximal
tissue-derived enteroids, enteroids in co-culture with
unstimulated BMDCs and enteroids in co-culture with LPS
(1 µg/ml) activated BMDCs.
Cytokine Enteroid
(pg/ml)
Enteroid+
BMDC (pg/ml)
Enteroid+ BMDC+
LPS (pg/ml)
IFN-γ 0.09 ± 0.02 0.05 ± 0.02 ND
IL-10 ND 98.42 ± 43.94 51.18 ± 30.89
IL-12 p70 ND 2.35 ± 2.03 320.85 ± 94.57
IL-15 0.40 ± 0.40 10.81 ± 6.37 186.74 ± 42.01*
IL-17A 0.01 ± 0.01 0.01 ± 0.01 1.51 ± 0.28*
IL-1β ND 0.61 ± 0.28 42.90 ± 5.36*
IL-33 0.60 ± 0.15 0.30 ± 0.19 4.97 ± 2.92
IL-6 2.14 ± 0.82 31.61 ± 14.81 43967.35 ± 4220.72*
KC/GRO 4.16 ± 0.55 5.52 ± 1.96 103.43 ± 30.89
TNF 2.29 ± 0.51 180.37 ± 78.95 806.86 ± 335.23
Analysis from three independent experiments in duplicate, data presented ±
SEM. ND= not detected. *p < 0.05 between enteroid+ BMDC+ LPS and
enteroid+ BMDC groups
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is therefore useful for determining dose and time points
for further investigations of a mechanistic nature, but
requires optimisation and validation for each culture
media formulation and damaging stimulus. The
mechanisms of rounding are unlikely to be the same for
all stimuli, however, this assay is particularly useful to
determining the morphological impact on intestinal epi-
thelia. Active caspase-3 is relatively stable compared with
other caspases and has a half-life of 8–11 h41 and was
detectable following TNF treatment for the entire time-
course of our experiments. We also assessed the expres-
sion of active caspase-8 and whilst this was observed at
the villus tip at early time-points as in previous studies29,
this caspase is much less stable, cleaved components p43
having a half-life of 63 ± 5min and p18 having a much
shorter half-life of 7 ± 1min42 and was not detected over
the whole time-course of our experiments in enteroids,
thus active caspase-8 activity did not positively correlate
with enteroid circularity.
Upregulation of NF-kB2 mRNA has been observed in
colitis-associated dysplasia and carcinoma43. Our previous
in vivo studies have also demonstrated that Nfκb2−/−
mice are less susceptible to the induction of experimental
colitis, colitis-associated cancer and LPS-induced SI cell
shedding17,20. However, the role of the intestinal epithe-
lium in contributing to this protection was previously
unclear as Nfκb2−/− mice have a perturbed immune
system that could have also contributed to the altered
phenotype44. We have now demonstrated that Nfκb2−/−
proximal SI epithelium is resistant to TNF and IFNγ
induced pathology in enteroids in the absence of con-
tributions from the other cellular compartments that are
present in vivo. This suggests that NF-κB2 signalling is an
important determinant of intestinal epithelial cell homo-
eostasis. A range of concentrations of cytokines was tested
in our experiments and alterations in circularity were
noted at concentrations greater than 10 ng/ml TNF and
0.1 ng/ml IFNγ. These concentrations are higher than
those detected in the circulation and tissues of human
patients, however, faecal concentrations have been noted
between 1 and 100 ng/g and are in line with the con-
centrations used in this study11. Murine TNF is a known
regulator of both classical and alternative pathway NF-κB
signalling and is likely to mediate its effects via TNFR1
and 2 ligation. However, it was surprising to also observe a
decreased sensitivity to IFNγ in Nfκb2−/− enteroids,
though this is likely to be via an indirect mechanism
resulting in the production of an NF-κB2 activator such as
BAFF45. In addition to TNF and IFNγ, many cytokines
contribute to the development of intestinal pathologies.
We generated a co-culture model incorporating enteroids
and BMDCs and showed that these cell populations could
co-exist without any change to enteroid morphology.
However, upon activation by LPS, BMDCs induced
signiﬁcant morphological changes in wild-type enteroids,
whereas Nfκb2−/− enteroids were seemingly protected.
Cytokines generated in the model included TNF and IFNγ
but both were produced at much lower concentrations
than were required alone to induce circularity changes in
enteroids and were similar to those observed in patients
with pathology. This suggests that other secreted factors
may also act synergistically with TNF and IFNγ to induce
enteroid rounding in this setting. IL-6 was produced in
abundance and could therefore contribute to modulating
epithelial cell dynamics. An in-depth investigation of the
BMDC secretome and assessment of cytokine combina-
tions is now warranted to determine how the intestinal
mucosal microenvironment regulates epithelial cell
dynamics in combination with genetic susceptibility that
may modulate the threshold for cytokines to induce a
pathological response.
These data suggest that the NF-κB2 signalling pathway,
speciﬁcally in intestinal epithelial cells, may be targetable
to ameliorate intestinal and systemic inﬂammation.
Materials and methods
Animals
Ten- to 12-week old wild-type C57BL/6J (Charles River,
Margate, UK) and NfκB1−/− and Nfκb2−/− mice44,46, bred
on the C57BL/6J genetic background were maintained at
the University of Liverpool under a 12:12 h light dark
cycle and fed a standard pelleted diet. All mice were
euthanized by cervical dislocation with ethical approval
under UK Home Ofﬁce legislation (Animals Scientiﬁc
Procedures Act 1986) and local ethical approval.
TNF treatment
Six female C57BL/6J mice were administered 0.33 mg/
kg murine recombinant TNF (Peprotech Ltd., London,
UK) by intraperitoneal injection and euthanized 1.5 h
later. Six untreated female C57BL/6J were used as con-
trols, mice were randomly allocated to two groups prior to
treatment. SIs were excised, ﬂushed with phosphate-
buffered saline (PBS) pH 7.4 and ﬁxed in 10% v/v neutral
buffered formalin maintaining orientation using pre-
viously described methods47.
Tissue preparation and scoring
Formalin-ﬁxed SI was divided up into proximal, middle
and distal thirds and bundled using methods previously
described47–49. Bundles were routinely processed,
embedded in parafﬁn wax in the transverse orientation
and 4 µm thick tissue sections were stained with haema-
toxylin and eosin (H&E), direct red 80 (both from Sigma,
Dorset, UK) or prepared for IHC.
For the quantiﬁcation of apoptotic and proliferative
intestinal epithelial cells in immunostained tissue sec-
tions, individual epithelial cells were counted from the
Jones et al. Cell Death and Disease          (2019) 10:896 Page 11 of 14
Ofﬁcial journal of the Cell Death Differentiation Association
base of the crypt to the mid-point of the villus tip in 20
well-orientated hemi crypt-hemi villi at 400× magniﬁca-
tion from 6 mice per group (group sizes of 6 were esti-
mated to be needed from previous studies to provide
appropriate statistical power and the scorer was blinded
to animal identiﬁer at the time of analysis)17. For the
quantiﬁcation of apoptotic and proliferative intestinal
epithelial cells in immunostained enteroid sections, indi-
vidual cells were counted in the total circumference of 6
whole enteroids from at least 3 independent replicate
studies at 400× magniﬁcation. Labelled cells were counted
if in continuation with the epithelial monolayer. Intestinal
epithelial cells were categorised according to the following
criteria:
1. Normal if there was no or weak non-speciﬁc brown
staining.
2. Apoptotic/mitotic if there was deﬁned positive
staining conﬁned to cytoplasmic or nuclear borders.
IHC and histochemical staining
Tissue and enteroid sections were deparafﬁnised and
rehydrated. Standard histochemical techniques were used
for H&E, direct red 80 (Sirius red) and alcian blue stain-
ing, the latter two being counterstained with haematox-
ylin to identify nuclei for quantiﬁcation.
Immunohistochemically stained slides were subjected to
1% v/v hydrogen peroxide in methanol to block endo-
genous peroxidases, followed by heat-mediated antigen
retrieval in 0.01M citrate acid buffer (pH 6) and then
blocked with 1% w/v bovine serum albumin (Sigma,
Dorset, UK). Rabbit polyclonal primary antibodies against
active caspase-3 (AF835; R&D Systems, Abingdon, UK),
Ki67 (AB15580; Abcam, Cambridge, UK) and
olfactomedin-4 (#39141; Cell Signalling Technology, UK)
were applied at 2.5, 2 and 0.25 μg/mL, respectively to
sections for 2 h and visualisation was completed using an
anti-rabbit Envision kit (Dako, Cambridge, UK) polymer
followed by peroxidase substrate 3,3′-diaminobenzidine
(DAB) (Sigma, Dorset, UK) using the manufacturer’s
instructions. Sections were counterstained with
haematoxylin.
Bone marrow-derived dendritic cell extraction and culture
Femurs and tibias were harvested from male C57BL/6J
wild-type mice and were mechanically cleaned to remove
any surrounding tissues. Bones were transferred into 70%
v/v ethanol for 2 min to sterilise their outsides. Bones
were clipped at the top and bottom and a 24 G needle was
used to ﬂush out the bone marrow through a 40 μm
cell sieve. Red blood cells were lysed, cells were quantiﬁed
and resuspended in dendritic cell differentiation
solution (RPMI containing GM-CSF (20 ng/ml),
β-mercaptoethanol (50 μM), 10% w/v FCS, 1% w/v glu-
tamine, 1% w/v penicillin/streptomycin; all from Sigma,
Dorset, UK) in 10 cm petri dishes at a concentration of
2.5 × 105/mL and plated at 20 mL/plate. Fresh media was
added to dishes 4 days following and non-adherent
BMDCs were used in experiments 7 days following iso-
lation and differentiation.
BMDC conditioned media was generated by plating
BMDCs in complete RPMI media as described above at
concentrations of 1 × 103, 1 × 104, 1 × 105 BMDC/mL.
BMDCs were removed from culture media by cen-
trifugation after 48 h and supernatants were immediately
used in enteroid assays.
Enteroid culture
Extraction and culture of SI crypts was carried out as
previously described32 with modiﬁcations as indicated
below. Male 10-week-old C57BL/6J mice were killed and
the SI was rapidly removed and ﬂushed with ice-cold
PBS. The most proximal, middle and most distal 2 cm
segments were isolated separately, opened out long-
itudinally, cut into 1 cm lengths and placed into PBS.
Intestinal segments were washed 10 times in ice-cold
PBS and incubated with ice-cold chelation buffer (20 mL
of 2 mM EDTA in PBS) at 4 oC with constant gentle
agitation for 30 min. Chelation buffer was then replaced
with 20 mL shaking buffer (43.3 mM sucrose, 59.4 mM
sorbitol; Sigma, Dorset, UK) and shaken gently for 30 s
to remove the majority of villi. Shaking buffer was
replaced with fresh shaking buffer (20 mL) and crypts
were then detached from the basal membrane by vig-
orous shaking by hand for 2 min. The crypt-enriched
supernatant was ﬁltered through a 70 μm cell strainer
(BD Biosciences Heidelberg, Germany) and quantiﬁed
using microscopy. The ﬁltered crypts were centrifuged
at 200 × g (4 °C, 10 min) and resuspended at
10,000 crypts/mL in Matrigel (BD Biosciences) con-
taining growth factors; epidermal growth factor (50 ng/
mL), R-spondin-1 (500 ng/mL) and Noggin (100 ng/mL)
(R&D Systems). Approximately, 500 crypts in 50 μL
Matrigel were seeded per well of a pre-warmed 24-well
ﬂat-bottomed plate and incubated at 37 °C for 10 min to
polymerise the Matrigel. Finally, 500 μL of minigut
culture medium was added to each well (advanced
DMEM/F12, 1% L-glutamine, 1% Pen/Strep, 10 mM
HEPES, 10 mM N2 supplement, 50 mM B27 supplement
(Invitrogen)) and crypts were cultured at 37 °C in a 95%
air, 5% CO2 atmosphere.
All enteroids were passaged at least once prior to use in
an experiment. Passage was carried out weekly at a
1:4 split ratio. Media was removed and enteroids in
Matrigel were resuspended in PBS and mechanically dis-
sociated into crypts by passing through a 27 G needle.
Dissociated enteroids were then centrifuged at 200 × g
(4 oC, 10 min), resuspended in fresh Matrigel containing
growth factors and plated as above. Culture medium was
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changed and replaced with new media containing growth
factors every 4 days.
Enteroid treatments
C57BL/6J, Nfκb1−/− and NFκb2−/− enteroids (passage
2–12) were treated 3 days following passage by adding
murine recombinant TNF (1–1000 ng/mL; PeproTech
Ltd., London, UK), IFNγ (01–100 ng/mL; Peprotech Ltd.),
C57BL/6J BMDCs (5 × 104/well) with or without 1 μg/mL
LPS diluted in 50% minigut media (containing 2× growth
factors) and 50% complete BMDC media or conditioned
media from BMDCs. High power images of 3 enteroids/
well, conducted in duplicate were taken at 0, 24 and 48 h
for circularity measurements and enteroids were har-
vested for histological analysis as described below.
Enteroid histology
Following treatment with TNF, media was removed and
replaced with 500 µL cell recovery solution (Corning, New
York, USA) and agitated at 4 °C until the Matrigel was
dispersed. Enteroids were then ﬁxed in 2% v/v neutral
buffered formalin. After 1-h ﬁxation enteroids were cen-
trifuged at 100×g for 1min. The supernatant was discarded
and 80–120 µl of pre-warmed HistogelTM (Thermo Sci-
entiﬁc, Massachusetts, USA) was mixed carefully with
enteroids and transferred directly onto a section of
MicroporeTM surgical tape forming a button when set.
Sections of tape with Histogel were transferred into
embedding cassettes and routinely processed and embed-
ded in parafﬁn wax. Sections of Histogel containing
enteroids (4 µm thick) were stained with H&E, direct red
80, or prepared for IHC as described above.
Enteroid circularity assessment
Bright ﬁeld microscopy was used to monitor enteroid
development from crypt isolation and throughout sub-
sequent passages and treatments. Images were taken using
an Axiovert 25 microscope (Zeiss) and a 20× objective lens
with a Hitachi HV-C20A camera. Enteroid morphology
was assessed throughout experiments using 2D bright ﬁeld
images and a software-based formula for calculating cir-
cularity: 4π (area)/perimeter2. Two-dimensional images of
enteroids were traced (three representative images per well
conducted in duplicate) and analysis was conducted by
recording enteroid area, perimeter and circularity using
the analyse and measure function in ImageJ software50.
Circularity values are possible between 0 and 1, with a
score of 1 indicating a perfect circle. The circularity
scoring method was adapted for enteroids from a pre-
viously reported system in mammary epithelial cultures51.
Cytokine analysis
Media was removed from enteroids and enteroids in co-
culture with BMDCs with and without LPS treatment 48 h
post culture and centrifuged to remove debris. Samples
were immediately frozen at −80 °C until further analysis
and defrosted only once for further usage. Samples were
run in duplicate and a multiplexing capable analysis plat-
form selected for simultaneous cytokine proﬁling
(QuickPlex SQ 120, Meso Scale Discovery, USA). The U-
plex mouse cytokine assay system was employed for the
analysis of a panel of markers as per manufacturer’s
instructions. Cytokines analysed were: IFNγ, TNF, KC/
GRO, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p70, IL-15,
IL-17, IL-23 and IL-33. Quantitative measurement of each
marker was achieved using a four-parameter logistic
regression method.
Statistical analysis
Student’s t tests were carried out on normally dis-
tributed data within proximal, middle and distal regions of
the SI and for cytokine production between LPS-treated
BMDCs and untreated BMDCs. All additional normally
distributed data were analysed by one-way ANOVA ver-
sus control group followed by Holm–Sidak post hoc
analysis. Statistical tests that achieved p < 0.05 were con-
sidered signiﬁcant.
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